Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-18-021571

Options or other derivatives

  • Chief Financial Officer acquired 166,001 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Saik Andrew · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-19 Grant or award : show line 1 in the form Stock Option (Right To Purchase) +166,001 166,001 D
Loading xslF345X03/form4.xml…